Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
amoxapine
|
| gptkbp:approvedBy |
1992
|
| gptkbp:ATCCode |
N06AA17
|
| gptkbp:brand |
gptkb:Amoxapine
Demolox |
| gptkbp:chemicalFormula |
C17H16ClN3O
|
| gptkbp:contraindication |
seizure disorders
recent myocardial infarction hypersensitivity to amoxapine |
| gptkbp:drugClass |
antidepressant
|
| gptkbp:eliminationHalfLife |
8-30 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Asendin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Wyeth
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
weight gain drowsiness dry mouth |
| gptkbp:usedFor |
gptkb:depression
|
| gptkbp:bfsParent |
gptkb:Amoxapine
|
| gptkbp:bfsLayer |
7
|